Remove 2020 Remove Customer Service Remove FDA
article thumbnail

QbD for biopharmaceutical product lifecycle management

European Pharmaceutical Review

In fact, the QbD approach promotes such a robust process control strategy that many regulatory bodies, such as the FDA 2 and EMA, encourage implementation of QbD for risk and quality management. Internet] FDA. 3 The detailed characterisation by QbD approaches ensures that safe and high-quality biologics are consistently produced.

article thumbnail

Do You Hear What I Hear? One Year of OTC Hearing Aids

The FDA Law Blog

When FDA released the final rule, it outlined its ambitious goals. However, FDA missed that deadline. FDA issued a proposed rule in 2021 and the final rule in August 2022 , culminating a seven-year effort involving three Administrations, Congress, FDA, and various stakeholders. Access has expanded.